SLC7A11 and Parkinson disease: p53 activation can downregulate Xc− by inhibiting SLC7A11, these actions further reduces the expression of GSH and GPX4, leading to DN loss and motor deficits in the PD mouse model.(Li S. S. et al., 2021).